Abstract. Complementary DNA (cDNA) clones corresponding to the major histocompatibility (MHC) class III antigen, complement protein C2, have been isolated from human liver cDNA libraries with the use of a complex mixture of synthetic oligonucleotides (17 mer) that contains 576 different oligonucleotide sequences. The C2 cDNA were used to identify a DNA restriction enzyme fragment length polymorphism that provides a genetic marker within the MHC that was not detectable at the protein level. An extensive search for genomic polymorphisms using a cDNA clone for another MHC class III gene, factor B, failed to reveal any DNA variants. The genomic variants detected with the C2 cDNA probe provide an additional genetic marker for analysis of MHClinked diseases.
Introduction
The genes for three of the serum complement proteins, the second (C2) and fourth (C4) components and factor B, have been localized to the major histocompatibility complex (MHC) in humans, mice, and guinea pigs (1) and have been designated class III MHC antigens. Human C4 is a three-chain glycoprotein -200,000 Mr coded for by two loci, C4A and C4B on the short arm of chromosome 6 (2) . The products of these loci differ structurally (3) and functionally (4) and several protein polymorphic variants have been identified for each locus (4) . Factors B and C2 are single chain glycoproteins of95,000 (5) and 102,000
Receivedfor publication 20 January 1984 and in revised form S April 1984. Mr (6) , respectively, which function in the alternative and classical pathways ofcomplement activation. Several genetic variants offactor B protein have been identified by differences in mobility on agarose electrophoresis. These have been useful in analysis of populations and families with MHC-linked disorders such as insulin dependent juvenile onset diabetes mellitus (7) . C2 protein variants have been recognized by isoelectric focusing of serum samples (8) in polyacrylamide gels and detected functionally by overlaying with an agarose gel containing antibody-sensitized sheep erythrocytes and either C2-deficient human serum or dilute normal human serum. These reveal a common variant, C2C, a basic variant in 4-5% of unrelated individuals designed C2B, and rarely an acidic variant (1) . Two such acidic C2 variants, designated C2 Al and C2 A2 have been recognized in <1% of the population. Individually, the class III gene products display less polymorphism than the class I and class II proteins.
Recently, cDNA clones corresponding to human and mouse class I and II histocompatibility antigens (HLA and H2) (9-13) and the class III proteins factor B (14, 15) and C4 (16) (17) (18) have been isolated and characterized. The availability ofcDNA probes for genes within the MHC have permitted an analysis of the fine structure of this region (13, 19) . Additional structural data derived from nucleotide sequencing will lead to an understanding of the molecular basis of polymorphic variants important in regulation of the immune response. DNA polymorphisms of the C4 genes have been identified by two groups (20, 21) . These C4 DNA polymorphisms were detected among individuals who were homozygous as defined by C4 protein variants. This permitted subdivision of the C4 variants already identified and therefore generated additional markers within the MHC. These results prompted efforts to isolate human C2 cDNA clones that could be used together with factor B cDNA (14) probes to generate additional markers for analysis of MHC-linked diseases. Genomic polymorphisms at a given locus are detected by digestion of DNA samples with restriction endonucleases that recognize specific nucleotide se-quences. The resulting DNA fragments are size-separated electrophoretically and transferred to nitrocellulose filters. Radiolabeled DNA probes are then used to detect fragments that contain complementary sequences (22) .
In this report, we describe the isolation of cDNA clones for human C2. The C2 clone and a factor B clone (14) have been used to investigate polymorphisms of these genes at the DNA level.
Methods
Isolation ofC2 cDNA clones. A 17-nucleotide long oligonucleotide mixture ( Fig. 1 ) was synthesized by a solid-phase phosphotriester method (14) . In position of nucleotide 7 and 13 for the glutamine (Gln) codons, 25% cytosine (C) was added as well as the guanosine (G) in order to obtain representation of the codon for glutamic acid (Glu). The oligonucleotide mixture was kinase labeled with [32P]dATP (23) and used to screen a human liver cDNA library, as described by Woods et al. (14) .
Approximately 40,000 clones were screened. The final posthybridization washes were at 45°C in 6 X SSC (0.15 M NaCl, 0.015 M Na citrate, and 0.05% sodium pyrophosphate).' Positive clones were colony purified and rescreened as described above. The five positive clones isolated were used as probes in Northern blot analysis (24) against human liver mRNA to determine if they hybridized to a mRNA of approximately the correct size. One of the clones, pC2-10 (-500 base pairs (bp)), was partially sequenced by using the Maxam and Gilbert sequencing procedure (23). pC2-10 was used to rescreen 200,000 clones of the human adult liver cDNA library ( 14) and 15 additional C2 clones were identified. The largest of these was pC2-6 (900 bp). This insert was used to screen a human fetal liver cDNA library (25) and a C2 clone (pC2-F2) of 1.6 kilobases (kb) was isolated.
Restriction enzyme analysis of human DNA. Restriction enzyme digestions were carried out and DNA samples were analyzed by the Southern blot technique (22). The insert from the C2 clone (pC2-6) and the factor B clone (pBfA28) (14) were nick translated (26) and used as probes.
Complement protein typing. Blood for genetic typing of BF, C2, and C4 was collected into 1 mg/ml of sodium ethylenediaminetetra-acetate (Na2 EDTA). Plasma was obtained by centrifugation and immediately frozen and stored at -80°C. The specimens were thawed immediately before analysis.
Plasma samples were subjected to agarose gel electrophoresis. Factor B patterns were visualized by immunofixation with goat anti-human B (Atlantic Antibodies, Scarborough, ME) as described previously (27) . For C2 typing, plasma samples were subjected to isoelectric focusing in polyacrylamide gels (8) 
Results
The C2 oligonucleotide mixture shown in Fig. 1 was kinase labeled and used as a probe to screen 40,000 clones of the human adult liver cDNA library. The nitrocellulose filters were washed in 6 X SSC at 45°C and autoradiographed. Under these conditions, five weakly hybridizing clones were identified. Analysis ofthese clones by hybridization to a Northern blot of human liver mRNA showed that only two clones hybridized to mRNA large enough to code for C2 i.e., -2.7 kb. One of these clones, pC2-10 (-500 bp), was partially sequenced by using Maxam and Gilbert DNA sequencing; the results are shown in Fig. 2 . This sequence represents the 5'-terminus of the clone, which corresponds to the amino-terminus of the C2a fragment (30) (the 70,000-D carboxyterminal fragment of C2 generated by the Cl enzyme during C2 activation) plus the nucleotides for five amino acids of the carboxyterminus of the C2b fragment. Fig. 2 also shows a comparison ofthe protein sequence generated from the cDNA sequence (a), the published sequence for the amino-terminus of human C2a (30) (b), and the published sequence of guinea pig C2a (30) (c). The amino acid sequence derived from the cDNA sequence is homologous to the published amino acid sequences for both human and guinea pig C2, thus identifying pC2-10 as a C2 cDNA clone. The amino acid sequence derived from the cDNA clone differs from the published human C2a protein sequence at residue 6 (Arg for Ser) and 10 (Leu for Lys). Differences between the derived human C2a sequences and the published sequence for guinea pig C2a (30) were evident at positions 18, 20, 24, 25, 27 and 28 (Fig. 2) .
DNA isolated from leukocytes of six unrelated individuals (30) . This sequence necessitated synthesis of an extremely complex mixture of oligonucleotides in order to include the authentic coding sequence (Fig. 1) . In the regions corresponding to amino acids at positions 3 and 5 (Glu) we constructed a mixture that contained 75% glutamine codons and 25% glutamic acid codons in order to account for possible protein sequencing errors. The resulting oligonucleotide mixture contained 576 different sequences. A difference was found between the amino acid at position 6 of the published sequence and that specified by the cDNA clone (pC2-10 
